Potential Role of P-Glycoprotein in Affecting Hepatic Metabolism of Drugs

被引：0
|
作者：
Win L. Chiou
Sang M. Chung
Ta C. Wu
机构：
[1] University of Illinois at Chicago,Department of Pharmaceutics and Pharmacodynamics (M/C865), College of Pharmacy
[2] University of Illinois at Chicago,Department of Pharmaceutics and Pharmacodynamics (M/C865), College of Pharmacy
来源：
Pharmaceutical Research | 2000年 / 17卷
关键词：
P-glycoprotein; hepatic metabolism; pharmacokinetics; first-pass metabolism; drug interaction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：903 / 905
页数：2
相关论文
共 50 条
  • [41] Interaction of antiepileptic drugs with human P-glycoprotein in vitro
    Weiss, J
    Kerpen, CJ
    Lindenmaier, H
    Dormann, SMG
    Haefeli, WE
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 307 (01): : 262 - 267
  • [42] Computer Regression Models for P-Glycoprotein Transport of Drugs
    V. Yu. Grigorev
    S. L. Solodova
    D. E. Polianczyk
    J. C. Dearden
    O. A. Raevsky
    Pharmaceutical Chemistry Journal, 2019, 52 : 975 - 979
  • [43] The role of P-glycoprotein and canalicular multispecific organic anion transporter in the hepatobiliary excretion of drugs
    Kusuhara, H
    Suzuki, H
    Sugiyama, Y
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 87 (09) : 1025 - 1040
  • [44] P-glycoprotein expression and stem cell potential
    Spratt, F
    Micallef, S
    Williams, B
    Cook, M
    Bertoncello, I
    EXPERIMENTAL HEMATOLOGY, 2000, 28 (07) : 68 - 69
  • [45] Role of P-Glycoprotein in Refractoriness of Seizures to Antiepileptic Drugs in Lennox-Gastaut Syndrome
    Kumar, Achal
    Tripathi, Deepak
    Paliwal, Vimal Kumar
    Neyaz, Zafar
    Agarwal, Vikas
    JOURNAL OF CHILD NEUROLOGY, 2015, 30 (02) : 223 - 227
  • [46] MDR1 P-glycoprotein reduces influx of substrates without affecting membrane potential
    Luker, GD
    Flagg, TP
    Sha, Q
    Luker, KE
    Pica, CM
    Nichols, CG
    Piwnica-Worms, D
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (52) : 49053 - 49060
  • [47] Allylbenzenes as potential chemosensitizers and P-glycoprotein inhibitors
    Martins, C.
    Armada, A.
    Viveiros, M.
    Rueff, J.
    Rodrigues, A. S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S178 - S178
  • [48] Therapeutic potential of nanocarrier for overcoming to P-glycoprotein
    Kaur, Vimratjeet
    Garg, Tarun
    Rath, Goutam
    Goyal, Amit K.
    JOURNAL OF DRUG TARGETING, 2014, 22 (10) : 859 - 870
  • [49] Prenylated xanthones as potential P-glycoprotein modulators
    Tchamo, DN
    Dijoux-Franca, MG
    Mariotte, AM
    Tsamo, E
    Daskiewicz, JB
    Bayet, C
    Barron, D
    Conseil, G
    Di Pietro, A
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (12) : 1343 - 1345
  • [50] Role of P-glycoprotein in pharmacokinetics - Clinical implications
    Lin, JH
    Yamazaki, M
    CLINICAL PHARMACOKINETICS, 2003, 42 (01) : 59 - 98
12345